Artificial intelligence (AI) and machine learning (ML) are making lung cancer treatment smarter and more effective by analyzing large amounts of medical data. They help doctors develop better medicines, predict how a patient might respond to a treatment, and choose the most suitable therapy for each individual. These technologies also improve how drugs are designed and delivered, making them more precise and effective. Overall, AI and ML are helping make cancer treatment more accurate, personalized, and efficient.
The report includes:
- Impact analysis of artificial intelligence (AI) on the global lung cancer therapeutics market
- Case studies for successful integration of AI and machine learning in drug discovery, biomarker identification, patient stratification and clinical trial optimization
- Highlights of AI adoption trends across major geographical regions, as well as disruptions caused by AI across key oncology, pharmaceutical and biotechnology industry verticals
- AI’s role in precision medicine, therapeutic development, treatment planning and clinical decision-making in lung cancer care
- Review of AI impact on the various stages of the global lung cancer therapeutics development and supply chain analysis
- Competitive landscape featuring key strategic initiatives, market spendings and an investment outlook
Table of Contents
Chapter 1 Key Use Cases for AI Implementation- Overview
- Key Use Cases
- Use Case 1: Manufacturing and Logistics
- Use Case 2: Healthcare
- Overview
- Adoption Trends by Region
- Adoption Trends in North America
- Adoption Trends in Europe
- Adoption Trends in Asia-Pacific
- Adoption Trends in the Rest of the World
- Overview
- Impact of AI on Key Industry Verticals
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Impact of AI on Various Stages of the Value Chain
- Biomarker Identification
- Manufacturing and Quality Control
- Streamlining Clinical Trials
- Overview
- Market Spending and Forecasting Analysis
- Key Spending by Lung Cancer Therapeutics Companies on AI
- Venture Capital Investment in AI Focused on Relevant Technologies and Products
- Notable Investments by Major Companies in AI
- Abbreviations Used in the Report
Table 1: Global Investment in Lung Cancer Therapeutics Market, 2024
Table 2: Key Spending by Companies on AI, 2025
Table 3: Key Spending by Companies on AI, 2021-2025
Table 4: Abbreviations Used in This Report
List of Figures
Figure 1: Value Chain for the Global Lung Cancer Therapeutics Market
